Глобальный рынок цифровой полимеразной цепной реакции (ПЦР) – тенденции отрасли и прогноз до 2031 года

Запрос на TOC Запрос на TOC Обратиться к аналитику Обратиться к аналитику Купить сейчас Купить сейчас Узнать перед покупкой Узнать перед покупкой Бесплатный пример отчета Бесплатный пример отчета

Глобальный рынок цифровой полимеразной цепной реакции (ПЦР) – тенденции отрасли и прогноз до 2031 года

  • Healthcare
  • Upcoming Report
  • Apr 2024
  • Global
  • 350 Pages
  • Количество таблиц: 220
  • Количество рисунков: 60

Global Digital Pcr Market

Размер рынка в млрд долларов США

CAGR :  % Diagram

Diagram Прогнозируемый период
2023 –2030
Diagram Размер рынка (базовый год)
USD 6,149.09 Million
Diagram Размер рынка (прогнозируемый год)
USD 13,586.21 Million
Diagram CAGR
%
Diagram Основные игроки рынка
  • covered
  • F. Hoffmann La Roche Ltd
  • BioRad Laboratories
  • Merck KGaA
  • Thermo Fisher Scientific

>Глобальный рынок цифровой полимеразной цепной реакции (ПЦР) по типу продукции (расходные материалы и реагенты для приборов цифровой ПЦР, программное обеспечение и услуги), технологиям (капельная цифровая ПЦР и лучевая цифровая ПЦР), применению (клиника, науки о жизни и исследования и др.), конечным пользователям (фармацевтические и биотехнологические компании, больницы и клиники, диагностические лаборатории, академические и исследовательские организации, референтные лаборатории и др.), каналам сбыта (прямые тендеры, розничные продажи и др.) — отраслевые тенденции и прогноз до 2031 г.

Рынок цифровой полимеразной цепной реакции (ПЦР)

Анализ и размер рынка цифровой полимеразной цепной реакции (ПЦР)

Рост числа больных диабетом обусловил спрос на точные диагностические инструменты, что привело к прогрессу на рынке цифровой полимеразной цепной реакции (ПЦР). Технология цифровой ПЦР обеспечивает высокочувствительное и точное обнаружение генетических маркеров, связанных с диабетом, помогая в ранней диагностике и персонализированных подходах к лечению. Ее способность обнаруживать редкие мутации и количественно определять целевую ДНК с высокой точностью делает ее бесценной для мониторинга прогрессирования заболевания и оценки эффективности лечения у больных диабетом. Более того, возможности автоматизации цифровой ПЦР оптимизируют процессы тестирования, повышая эффективность клинических лабораторий и обеспечивая быструю обработку результатов для пациентов.

Объем мирового рынка цифровой полимеразной цепной реакции (ПЦР) в 2023 году оценивался в 6,83 млрд долларов США, а к 2031 году, по прогнозам, он достигнет 15,86 млрд долларов США, при среднегодовом темпе роста 11,1% в прогнозируемый период с 2024 по 2031 год. Помимо аналитических данных о рыночных сценариях, таких как рыночная стоимость, темпы роста, сегментация, географический охват и основные игроки, рыночные отчеты, подготовленные Data Bridge Market Research, также включают в себя углубленный экспертный анализ, эпидемиологию пациентов, анализ конвейера, анализ цен и нормативную базу.

Область отчета и сегментация рынка       

Отчет Метрика

Подробности

Прогнозируемый период

2024-2031

Базовый год

2023

Исторические годы

2022 (Можно настроить на 2016-2021)

Количественные единицы

Выручка в млрд долл. США, объемы в единицах, цены в долл. США

Охваченные сегменты

Тип продукта (цифровые приборы ПЦР, расходные материалы и реагенты, программное обеспечение и услуги), технология (капельная цифровая ПЦР и лучевая цифровая ПЦР), применение (клиника, науки о жизни и исследования и др.), конечный пользователь (фармацевтические и биотехнологические компании, больницы и клиники, диагностические лаборатории, академические и исследовательские организации, референтные лаборатории и др.), канал сбыта (прямые тендеры, розничные продажи и др.)

Страны, охваченные

U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

Market Players Covered

F. HoffmannLa Roche Ltd (Switzerland), BioRad Laboratories Inc. (U.S.), Merck KGaA (Germany), Thermo Fisher Scientific Inc. (U.S.), QIAGEN (Netherlands), Eppendorf SE (Germany), Sysmex Inostics Inc. (Japan), Stilla (France), RainSure Scientific (U.S.), Accumax (India), Standard BioTools (U.S.), JN Medsys (Singapore), VSI Electronics Pvt. Ltd (India), Precigenome LLC (U.S.)

Market Opportunities

  • High Prevalence Of Cancer leads to the Adoption of Digital PCR Technology
  • Rising Demand for Precision Medicine in the Management of Chronic Disorders

Market Definition

Digital PCR quantifies and amplifies nucleic acids such as DNA, cDNA, or RNA by partitioning samples into numerous small reactions and detecting positive ones. It offers superior sensitivity and accuracy compared to traditional PCR methods, making it ideal for applications demanding precise detection of minimal nucleic acid inputs or nuanced target amount distinctions. Its efficacy shines in rare sequence detection, copy number variation (CNV) analysis, and gene expression profiling of low-abundance targets.

Digital Polymerase Chain Reaction (PCR) Market Dynamics

Drivers

  • Rise in Availability of Digital PCR Diagnostics Leads to Increased Infectious Disease Monitoring

Digital PCR offers unparalleled sensitivity, precision, and accuracy in detecting and quantifying nucleic acids, making it indispensable in various diagnostic applications. Its ability to detect rare mutations, quantify viral load, and assess gene expression levels with high sensitivity has made it a preferred choice in clinical diagnostics, infectious disease monitoring, and oncology. Additionally, advancements such as customized assay design services and integrated systems have further expanded its utility, driving market adoption. As healthcare systems increasingly prioritize precision medicine and personalized diagnostics, the demand for digital PCR technologies is expected to continue rising, fostering market expansion and innovation.

  • Growing Research and Development Activities Enhances Speed of Digital PCR Systems

Innovations in product development, driven by R&D efforts, continuously enhance the efficiency, accuracy, and speed of digital PCR systems. These advancements cater to the increasing demand for precise nucleic acid quantification in various fields such as biotechnology, healthcare, and diagnostics. R&D initiatives focus on improving key aspects such as multiplexing capabilities, assay sensitivity, and automation, enabling researchers to address complex biological questions with greater precision and throughput. Consequently, the market witnesses sustained expansion as organizations invest in R&D to stay competitive and meet evolving customer needs for advanced molecular analysis technologies.

Opportunities

  • High Prevalence of Cancer Leads to the Adoption of Digital PCR Technology

Digital PCR offers unparalleled sensitivity and precision in detecting and quantifying nucleic acids, making it particularly valuable for cancer diagnosis, monitoring, and treatment. Its ability to detect rare mutations or trace amounts of tumor DNA in bodily fluids enables early detection and personalized therapy approaches. Moreover, as cancer incidence rates continue to rise globally, there is a growing demand for robust molecular diagnostic tools such as digital PCR to support oncology research and clinical practice. This trend has fueled investments in digital PCR technology, driving market growth and innovation in cancer diagnostics and therapeutics.

In 2021, as highlighted by the American Cancer Society's statistics, accentuates the critical role of advanced molecular diagnostics such as Digital PCR in cancer management. With nearly 1.9 million new cases of cancer in the U.S. alone in 2021, there is an urgent need for sensitive and precise diagnostic tools to enable early detection and personalized treatment strategies. Digital PCR's unparalleled sensitivity to detect rare mutations and trace tumor DNA in bodily fluids positions it as a pivotal technology in oncology research and clinical practice, aiding in improving patient outcomes and reducing the global cancer burden.

  • Rising Demand for Precision Medicine in the Management of Chronic Disorders

Digital PCR offers unparalleled accuracy and sensitivity in quantifying nucleic acids, making it an ideal tool for the precise diagnosis, monitoring, and personalized treatment of chronic conditions. Its ability to detect rare genetic mutations and variations with high precision allows for tailored therapeutic approaches, enhancing patient outcomes and reducing healthcare costs associated with trial-and-error treatments. Furthermore, the expanding applications of digital PCR in companion diagnostics and pharmacogenomics further bolster its potential in driving advancements in precision medicine.

Amerigo Scientific's expansion of its cell culture portfolio in August 2021 highlights the growing market opportunity in 3D cell culture. It introduces a new 3D cell culture system tailored for scientific applications such as drug discovery, medicine, nanomaterial evaluation, and basic life science research, Amerigo Scientific is capitalizing on the increasing demand for advanced cell culture technologies. This move underscores the industry's momentum towards leveraging innovative solutions to enhance research efficacy and address complex biological challenges.

Restraints/Challenges

  • High Cost of Implementation Limits the Adoption of 3D Cell Culture Techniques

As devices become increasingly sophisticated and diverse in their functionalities, conventional PCR systems may struggle to accommodate their unique requirements effectively. This limitation can hinder the ability of PCR technologies to accurately detect and quantify nucleic acids in complex devices, potentially leading to suboptimal results and reduced utility in certain applications.

  • Shortage of Skilled Professionals Leads to Potential Errors

Without adequate expertise, users may encounter difficulties in operating complex PCR systems, leading to potential errors in experimental setup, data interpretation, and result analysis. These errors can compromise the accuracy and reliability of nucleic acid quantification, undermining the trust in digital PCR technology. Additionally, the shortage hampers the adoption of advanced PCR techniques, limiting the market growth as organizations struggle to fully leverage the capabilities of digital PCR platforms for research, diagnostics, and therapeutics.

This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Developments

  • In July 2023, QIAGEN collaborates with Niba Labs to enhance its digital PCR offerings for the biopharma sector, providing tailored dPCR assay design services. This collaboration leverages Niba Labs' expertise in assay development and sample testing, enabling QIAcuity customers to access custom simplex or multiplex assays for nucleic acid quantification
  • In September 2021, ThermoFisher Scientific launches a fully integrated digital PCR system, promising precise and consistent results in just 90 minutes. This system represents a significant advancement in PCR technology, catering to researchers' need for rapid and accurate nucleic acid analysis
  • In July 2021, Stilla Technologies launches it’s sic Color Crystal Digital PCR access program, granting the industry early access to its digital PCR system equipped with six fluorescent channels. This initiative aims to accelerate research and development efforts by providing advanced PCR technology capable of high-resolution nucleic acid analysis

Digital Polymerase Chain Reaction (PCR) Market Scope

The market is segmented on the basis of product type, technology, application, end user, and distribution channel. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.  

Product Type

  • Digital PCR Instruments
  • Consumables and Reagents
  • Software and Services

Technology

  • Droplet Digital PCR
  • Beaming Digital PCR

Application

  • Clinical
  • Life Science and Research
  • Others

End User

  • Pharmaceutical and Biotechnology Companies
  • Hospitals and Clinics
  • Diagnostic Laboratories
  • Academic and Research Organizations
  • Reference Laboratories
  • Others

Distribution Channel

  • Direct Tenders
  • Retail Sales
  • Others

Digital Polymerase Chain Reaction (PCR) Market Regional Analysis/Insights

The market is segmented into five notable segments based on product type, application, technology, end user, and distribution channel.   

The countries covered in this market report U.S., Canada, Mexico, Germany, France, Italy, Spain. U.K., Switzerland, Netherlands, Russia, Turkey, Sweden, Belgium, Poland, Norway, Finland, Denmark, Rest of Europe, Japan, China, India, South Korea, Australia, New Zealand, Singapore, Thailand, Indonesia, Malaysia, Philippines, Vietnam, Taiwan, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, U.A.E., Egypt, Bahrain, Qatar, Oman, Saudi Arabia, Kuwait, and Rest of Middle East and Africa.   

In North America, U.S. is expected to dominate the digital PCR market, fueled by rising investments in this technology. It hold the forefront position, primarily attributed to the substantial presence of key industry players. This dominance underscores the country's robust infrastructure, technological advancements, and strategic initiatives driving the adoption of digital PCR solutions.

In Europe, Germany is expected to dominate the market due to several factors, including its strong industrial base, advanced infrastructure, and strategic geographical location. The country's robust economy and technological expertise position it as a key player in meeting the growing demand for various products and services across emerging markets within Europe. Additionally, Germany's proactive approach towards expansion initiatives and its emphasis on innovation further contribute to its anticipated dominance in the region's market landscape.

In Asia-Pacific, China is expected to dominate the market due to rising customer preferences for this technology. Factors such as the growing awareness of the benefits of digital PCR, including its higher sensitivity and accuracy, are driving adoption. Additionally, China's robust biopharmaceutical sector and investment in life sciences research contribute to the country's leading position in embracing advanced molecular diagnostic technologies such as digital PCR. This trend suggests a significant market opportunity for digital PCR manufacturers and service providers looking to expand their presence in the region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure Growth Installed base and New Technology Penetration

The market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the market. The data is available for historic period 2016-2021.

Competitive Landscape and Digital Polymerase Chain Reaction (PCR) Market Analysis

The market competitive landscape provides details of competitors. Details included are company overview, company financials, revenue generated, market potential, investment in R&D, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product approvals, product width and breadth, application dominance, and product type lifeline curve. The above data points provided are only related to the company’s focus on the market.

Some of the major players operating in the market are:

  •  F. HoffmannLa Roche Ltd (Switzerland)
  •  BioRad Laboratories Inc. (U.S.)
  •  Merck KGaA (Германия)
  •  Thermo Fisher Scientific Inc. (США)
  •  QIAGEN (Нидерланды)
  •  Эппендорф СЕ (Германия)
  •  Sysmex Inostics Inc. (Япония)
  •  Стилла (Франция)
  •  RainSure Scientific (США)
  •  Аккумакс (Индия)
  •  Стандартные BioTools (США)
  •  JN Medsys (Сингапур)
  •  VSI Electronics Pvt. Ltd (Индия)
  •  Precigenome LLC (США)


SKU-

Get online access to the report on the World's First Market Intelligence Cloud

  • Интерактивная панель анализа данных
  • Панель анализа компании для возможностей с высоким потенциалом роста
  • Доступ аналитика-исследователя для настройки и запросов
  • Анализ конкурентов с помощью интерактивной панели
  • Последние новости, обновления и анализ тенденций
  • Используйте возможности сравнительного анализа для комплексного отслеживания конкурентов
Запросить демонстрацию

Методология исследования

Сбор данных и анализ базового года выполняются с использованием модулей сбора данных с большими размерами выборки. Этап включает получение рыночной информации или связанных данных из различных источников и стратегий. Он включает изучение и планирование всех данных, полученных из прошлого заранее. Он также охватывает изучение несоответствий информации, наблюдаемых в различных источниках информации. Рыночные данные анализируются и оцениваются с использованием статистических и последовательных моделей рынка. Кроме того, анализ доли рынка и анализ ключевых тенденций являются основными факторами успеха в отчете о рынке. Чтобы узнать больше, пожалуйста, запросите звонок аналитика или оставьте свой запрос.

Ключевой методологией исследования, используемой исследовательской группой DBMR, является триангуляция данных, которая включает в себя интеллектуальный анализ данных, анализ влияния переменных данных на рынок и первичную (отраслевую экспертную) проверку. Модели данных включают сетку позиционирования поставщиков, анализ временной линии рынка, обзор рынка и руководство, сетку позиционирования компании, патентный анализ, анализ цен, анализ доли рынка компании, стандарты измерения, глобальный и региональный анализ и анализ доли поставщика. Чтобы узнать больше о методологии исследования, отправьте запрос, чтобы поговорить с нашими отраслевыми экспертами.

Доступна настройка

Data Bridge Market Research является лидером в области передовых формативных исследований. Мы гордимся тем, что предоставляем нашим существующим и новым клиентам данные и анализ, которые соответствуют и подходят их целям. Отчет можно настроить, включив в него анализ ценовых тенденций целевых брендов, понимание рынка для дополнительных стран (запросите список стран), данные о результатах клинических испытаний, обзор литературы, обновленный анализ рынка и продуктовой базы. Анализ рынка целевых конкурентов можно проанализировать от анализа на основе технологий до стратегий портфеля рынка. Мы можем добавить столько конкурентов, о которых вам нужны данные в нужном вам формате и стиле данных. Наша команда аналитиков также может предоставить вам данные в сырых файлах Excel, сводных таблицах (книга фактов) или помочь вам в создании презентаций из наборов данных, доступных в отчете.

Часто задаваемые вопросы

The market is segmented based on Global Digital Polymerase Chain Reaction (PCR) Market, By Product Type (Digital PCR Instruments Consumables and Reagents and Software and Services), Technology (Droplet Digital PCR and Beaming Digital PCR), Application (Clinical, Life Science and Research, and Others), End User (Pharmaceutical and Biotechnology Companies, Hospitals and Clinics, Diagnostic Laboratories, Academic and Research Organizations, Reference Laboratories, and Others), Distribution Channel (Direct Tenders, Retail Sales, and Others) – Industry Trends and Forecast to 2031. .
The Global Digital Pcr Market size was valued at USD 6149.09 USD Million in 2022.
The Global Digital Pcr Market is projected to grow at a CAGR of 11.1% during the forecast period of 2023 to 2030.
The major players operating in the market include covered, F. Hoffmann La Roche Ltd, BioRad Laboratories , Merck KGaA, Thermo Fisher Scientific , QIAGEN, Eppendorf SE, Sysmex Corporation, Stilla, RainSure Scientific, Accumax, Standard BioTools, JN Medsys, VSI Electronics Pvt. Ltd, Precigenome LLC.
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.